Company / Capital Expenditures
Bluejay Diagnostics, Inc. Capital Expenditures History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$704.2K
FY2023
5-year range
$704.2K / $1.2M
FY2022-FY2023
Trend
-41.3%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$704,166 in FY2023.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, capital expenditures decreased 41.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $704.2K | -41.3% |
| FY2022 | $1.2M | - |
As of FY2023 · SEC Form 10-K · Last checked Jun 22, 2026